FDA Panel Sets Stage for 'Landmark Approval' of HER2 DrugFDA Panel Sets Stage for 'Landmark Approval' of HER2 Drug

Pertuzumab could be the first medicine approved for the neoadjuvant treatment of breast cancer. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news